A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab.
Oncol Res
; 28(7): 801-809, 2021 Sep 07.
Article
in En
| MEDLINE
| ID: mdl-34030768
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Plantas_medicinales
Main subject:
Silymarin
/
Camptothecin
/
Colorectal Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Protective Agents
/
Bevacizumab
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Oncol Res
Year:
2021
Type:
Article